
- Volume 0 0
Zestra Reports Positive Results of OTC Feminine Arousal Fluid
A study of nonhormonal, nonprescription feminine arousal fluid from Zestra Laboratories to improve women's sexual experiences showed positive results when compared a placebo oil among the 178 women diagnosed with sexual difficulties who completed the study.
Results were tabulated using the Female Sexual Function Index, a widely used self-assessment questionnaire. A significant benefit of Zestra's fluid was shown over placebo in the desire/satisfaction component. In the arousal component, Zestra's fluid showed a highly significant benefit over placebo. While the FDA does not require clinical trials of nonprescription consumer products, Zestra Laboratories elected to run the trials to assess safety and effectiveness. The product is widely available in drug, supermarket, and discount chain stores.
Articles in this issue
about 18 years ago
Actemra Found to Relieve RA Symptomsabout 18 years ago
Trial of New Weight-loss Pill Leaves Patients Feeling Fullabout 18 years ago
Oral Care Products and the Diabetic Patientabout 18 years ago
FOLIC ACID REDUCES RISK OF STROKEabout 18 years ago
FDA APPROVES UPDATED WARFARIN INFOabout 18 years ago
FONDAPARINUX MAY BE OPTION FOR HITabout 18 years ago
diabetes PRODUCT chartsabout 18 years ago
Hyperthermia, Chemotherapy Aid High-risk Cancer Patientsabout 18 years ago
High Blood Pressure: Getting the Most Out of Home Monitoringabout 18 years ago
can you READ these Rxs?Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.